Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.002 |